
The planned trials of experimental Ebola drugs in West Africa do not have the full support of medical experts because there is not enough proof that these drugs work, the World Health
Organization (WHO) said Friday, dpa reported.
There are only a small number of really promising drugs, WHO official Martin Friede said, dampening hopes for a quick cure for Ebola.
The medical aid group Medecins Sans Frontieres (MSF) announced Thursday that it planned tests starting in December of the Japanese influenza drug Favipiravir in Guinea and the US experimental antiviral drug Brincidofovir at a location to be determined.
MSF chose these two drugs because they would be quickly available in large amounts if the trial results are positive.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor